Regulation of cyclin D1 gene expression
- PMID: 20074063
- DOI: 10.1042/BST0380217
Regulation of cyclin D1 gene expression
Abstract
Cyclin D1 is a key regulator of cell proliferation and its expression is subject to both transcriptional and post-transcriptional regulation. In different cellular contexts, different pathways assume a dominant role in regulating its expression, whereas their disregulation can contribute to overexpression of cyclin D1 in tumorigenesis. Here, we discuss the ability of the NF-kappaB (nuclear factor kappaB)/IKK [IkappaB (inhibitor of NF-kappaB) kinase] pathways to regulate cyclin D1 gene transcription and also consider the newly discovered role of the SNARP (SNIP1/SkIP-associated RNA processing) complex as a co-transcriptional regulator of cyclin D1 RNA stability.
Similar articles
-
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.Mol Cancer Res. 2005 Feb;3(2):100-9. doi: 10.1158/1541-7786.MCR-04-0070. Mol Cancer Res. 2005. PMID: 15755876
-
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.Clin Cancer Res. 2007 Apr 1;13(7):2236-45. doi: 10.1158/1078-0432.CCR-06-2308. Clin Cancer Res. 2007. PMID: 17404108
-
Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.Cancer Sci. 2008 May;99(5):952-7. doi: 10.1111/j.1349-7006.2008.00787.x. Epub 2007 Mar 12. Cancer Sci. 2008. PMID: 18341653
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.Oncogene. 2006 Oct 30;25(51):6685-705. doi: 10.1038/sj.onc.1209934. Oncogene. 2006. PMID: 17072322 Review.
Cited by
-
Targeting NF-κB signaling cascades of glioblastoma by a natural benzophenone, garcinol, via in vitro and molecular docking approaches.Front Chem. 2024 Feb 16;12:1352009. doi: 10.3389/fchem.2024.1352009. eCollection 2024. Front Chem. 2024. PMID: 38435669 Free PMC article.
-
TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma.Medicine (Baltimore). 2023 Dec 1;102(48):e36410. doi: 10.1097/MD.0000000000036410. Medicine (Baltimore). 2023. PMID: 38050264 Free PMC article.
-
RSK2 promotes melanoma cell proliferation and vemurafenib resistance via upregulating cyclin D1.Front Pharmacol. 2022 Sep 20;13:950571. doi: 10.3389/fphar.2022.950571. eCollection 2022. Front Pharmacol. 2022. PMID: 36210843 Free PMC article.
-
Genome-wide comparison and in silico analysis of splicing factor SYF2/NTC31/p29 in eukaryotes: Special focus on vertebrates.Front Genet. 2022 Sep 2;13:873869. doi: 10.3389/fgene.2022.873869. eCollection 2022. Front Genet. 2022. PMID: 36118875 Free PMC article.
-
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer.NPJ Breast Cancer. 2022 Jan 10;8(1):1. doi: 10.1038/s41523-021-00377-8. NPJ Breast Cancer. 2022. PMID: 35013314 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
